CSIMarket Company Name, Ticker, Industry, else..
 
Maia Biotechnology Inc   (NYSEAMER: MAIA)
 
Price: $1.3100 $-0.01 -0.758%
Day's High: $1.3480000495910645 Week Perf: 0.77 %
Day's Low: $ 1.30 30 Day Perf: -7.75 %
Volume (M): 222,498 52 Wk High: $ 3.19
Volume (M$): $ 0 52 Wk Avg: $1.47
Open: $1.32 52 Wk Low: $0.87



 Market Capitalization (Millions $) 80
 Shares Outstanding (Millions) 61
 Employees 13
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -27
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Maia Biotechnology Inc is a biotechnology company that focuses on developing novel therapies for cancer. The company combines expertise in genomics, bioinformatics, and drug discovery to identify and target key genes and pathways involved in various cancers. Maia Biotechnology's goal is to create innovative treatments that have the potential to improve patient outcomes and revolutionize cancer care.


   Company Address: 444 West Lake Street Chicago 60606 IL
   Company Phone Number: 416-8592   Stock Exchange / Ticker: NYSEAMER MAIA


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
APRE        4.37% 
APVO   -22.95%    
ATOS        2% 
BGMS   -1.62%    
MRKR   -3.76%    
VSTM        11.91% 
• View Complete Report
   



Stocks on the Move

MAIA Biotechnologys Telomere Targeting Functionality Enhances Cancer Treatment

Published Fri, Jun 28 2024 4:53 AM UTC

In recent years, MAIA Biotechnology, Inc. (NYSE American: MAIA) has emerged as a leading player in the field of targeted immunotherapies for cancer. With a focus on telomere-targeting functionality, the company s groundbreaking approach is paving the way for more effective and personalized cancer treatments. With recent achievements and FDA approval of a telomerase inhibitor...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 3.85
PEG (TTM) -

Financial Strength Current
Quick Ratio 4.41
Working Capital Ratio 4.52
Leverage Ratio (MRQ) 0.37
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.65 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash 0.45 $
Book Value 0.34 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -2,065,015
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.